ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012

Institute Of Medicine: External Experts Should Vet Large Projects, Report Says.

June 20, 2003

Chart Show 1980 Budget Breakown By Mechanisms, Research Programs, Compare Them With Previous Years

June 9, 1978

Ontak Approved For Lymphoma

October 31, 2008

At Least 25 CCOP Applicants Score High Enough To Virtually Assure Funding; Geography An Issue

May 13, 1983

High Risk Youth Targeted In Concept Ok’d By Advisors

February 8, 1991